Franklin Street Advisors’s Pfizer PFE Stock Holding History

Franklin Street Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Buy	46,667 +14	+0%	+$366	0.06%	80
2026 Q1	$1.31M	Buy	46,653 +249	+0.5%	+$6.63K	0.08%	72
2025 Q4	$1.16M	Buy	46,404 +73	+0.2%	+$1.84K	0.07%	74
2025 Q3	$1.18M	Sell	46,331 -8,500	-16%	-$210K	0.07%	74
2025 Q2	$1.33M	Buy	54,831 +11,668	+27%	+$272K	0.08%	76
2025 Q1	$1.09M	Buy	43,163 +10	+0%	+$262	0.08%	81
2024 Q4	$1.15M	Sell	43,153 -13,189	-23%	-$358K	0.08%	81
2024 Q3	$1.63M	Buy	56,342 +13,643	+32%	+$398K	0.11%	73
2024 Q2	$1.2M	Sell	42,699 -1,245	-3%	-$34.3K	0.09%	77
2024 Q1	$1.22M	Sell	43,944 -518	-1%	-$14.4K	0.09%	68
2023 Q4	$1.28M	Buy	44,462 +97	+0.2%	+$2.93K	0.1%	69
2023 Q3	$1.47M	Sell	44,365 -431	-1%	-$15.2K	0.13%	64
2023 Q2	$1.64M	Buy	44,796 +12,072	+37%	+$470K	0.14%	67
2023 Q1	$1.33M	Sell	32,724 -5,151	-14%	-$222K	0.12%	65
2022 Q4	$1.94M	Sell	37,875 -1,135	-3%	-$54.4K	0.18%	63
2022 Q3	$1.71M	Buy	39,010 +282	+0.7%	+$13.7K	0.17%	69
2022 Q2	$2.03M	Sell	38,728 -43,284	-53%	-$2.21M	0.19%	66
2022 Q1	$4.25M	Sell	82,012 -33,351	-29%	-$1.73M	0.34%	57
2021 Q4	$6.81M	Buy	115,363 +4,562	+4%	+$226K	0.51%	51
2021 Q3	$4.77M	Sell	110,801 -1,943	-2%	-$86.1K	0.4%	56
2021 Q2	$4.42M	Sell	112,744 -16,199	-13%	-$630K	0.37%	57
2021 Q1	$4.67M	Sell	128,943 -201,387	-61%	-$7.15M	0.43%	56
2020 Q4	$12.2M	Buy	330,330 +114,179	+53%	+$4.19M	1.18%	31
2020 Q3	$7.53M	Buy	216,151 +188,821	+691%	+$6.62M	0.81%	48
2020 Q2	$848K	Sell	27,330 -331	-1%	-$11.2K	0.1%	78
2020 Q1	$857K	Sell	27,661 -4,781	-15%	-$163K	0.12%	74
2019 Q4	$1.21M	Sell	32,442 -150	-0.5%	-$5.34K	0.14%	75
2019 Q3	$1.11M	Sell	32,592 -3,662	-10%	-$133K	0.14%	79
2019 Q2	$1.49M	Sell	36,254 -577	-2%	-$22.9K	0.19%	70
2019 Q1	$1.48M	Sell	36,831 -443	-1%	-$17.7K	0.21%	72
2018 Q4	$1.54M	Sell	37,274 -329	-0.9%	-$13.7K	0.24%	66
2018 Q3	$1.57M	Buy	37,603 +4,627	+14%	+$178K	0.21%	69
2018 Q2	$1.14M	Sell	32,976 -738	-2%	-$25.2K	0.17%	77
2018 Q1	$1.14M	Sell	33,714 -1,384	-4%	-$47.6K	0.17%	79
2017 Q4	$1.21M	Buy	35,098 +922	+3%	+$31.4K	0.18%	81
2017 Q3	$1.16M	Buy	34,176 +915	+3%	+$29.4K	0.19%	84
2017 Q2	$1.06M	Sell	33,261 -763	-2%	-$24.1K	0.18%	82
2017 Q1	$1.1M	Sell	34,024 -1,965	-5%	-$62K	0.19%	85
2016 Q4	$1.11M	Sell	35,989 -509	-1%	-$15.5K	0.2%	92
2016 Q3	$1.17M	Sell	36,498 -1,892	-5%	-$63.3K	0.21%	94
2016 Q2	$1.28M	Sell	38,390 -2,908	-7%	-$92.8K	0.24%	90
2016 Q1	$1.16M	Buy	41,298 +7,060	+21%	+$202K	0.23%	102
2015 Q4	$1.05M	Sell	34,238 -643	-2%	-$20.2K	0.21%	112
2015 Q3	$1.04M	Sell	34,881 -74	-0.2%	-$2.37K	0.21%	114
2015 Q2	$1.11M	Buy	34,955 +3,227	+10%	+$105K	0.2%	109
2015 Q1	$1.05M	Buy	31,728 +4,066	+15%	+$129K	0.19%	111
2014 Q4	$818K	Buy	27,662 +350	+1%	+$10K	0.16%	117
2014 Q3	$766K	Buy	27,312 +79	+0.3%	+$2.22K	0.15%	133
2014 Q2	$767K	Buy	27,233 +110	+0.4%	+$3.14K	0.15%	135
2014 Q1	$826K	Sell	27,123 -1,199	-4%	-$35.7K	0.17%	132
2013 Q4	$823K	Hold	28,322	–	–	0.17%	131
2013 Q3	$772K	Sell	28,322 -1,716	-6%	-$46.7K	0.17%	135
2013 Q2	$798K	Buy	+30,038	New	+$830K	0.2%	135

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Franklin Street Advisors's PFE Position: Q2 2026 in Review

Franklin Street Advisors increased its Pfizer (PFE) stake by 0.03% in Q2 2026, buying an estimated $366 and bringing the position to 46,667 shares worth $1.12M. The position accounts for 0.06% of the portfolio, ranked #80.

Franklin Street Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.2M in Q4 2020. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Franklin Street Advisors held 46,667 shares of Pfizer worth $1.12M as of Q2 2026.
Franklin Street Advisors bought 14 Pfizer shares in Q2 2026, an estimated $366.
Pfizer made up 0.06% of Franklin Street Advisors's portfolio in Q2 2026, its #80 holding.
Franklin Street Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Franklin Street Advisors's Pfizer position peaked at $12.2M in Q4 2020.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.